References Journal of Endocrinology and Metabolism (2014) Safety and metabolism of AOD9604 as a nutraceutical ingredient
If the label just says "Magnesium," it is likely a low-quality form
The synthesis of the subunits of the enzymatic protein is also repressed
Additionally, these medications may reduce systemic inflammation, a key driver of atherosclerosis (plaque buildup in arteries)
Alterations in the microbial flora, gut inflammation, increased intestinal barrier permeability (forming a leaky gut), bacterial translocation, and exposure to stressful environments in schizophrenia (144, 152, 156), may trigger innate immunity via TLR4 stimulation